IMP761

· Immutep S.A.S.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMP761, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers [Phase 1]